This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
TherapeuticsMD, Inc. (NYSE MKT:TXMD) a women’s health care company, ("TherapeuticsMD" or the "Company") announced today that it will webcast its upcoming Investor Day on June 16, 2014 to be held at the InterContinental Barclay New York in New York City commencing promptly at 11:30 a.m. EDT to approximately 2:30 p.m.
At the event, TherapeuticsMD's senior management team will make remarks regarding the Company's product development pipeline and future prospects. The event will feature a panel of prominent experts on women’s health and hormone therapy, the compounding market, and relevant legislative and regulatory topics. The presentation may include forward-looking statements.
Institutional investors and analysts who would like to attend in person may register by contacting Lisa Wilson at 917-543-9932 or by e-mail at
firstname.lastname@example.org, or may register online at the home page of the Company's website at
www.TherapeuticsMD.com. For individuals attending in person, onsite registration and lunch will begin at 11:00 a.m. with the presentation commencing promptly at 11:30 a.m.
Investors and other interested parties who are unable to attend in person are invited to participate in a simultaneous webcast through the Company's website at
www.TherapeuticsMD.com, both on the home page and under the
Investors tab. It is recommended that online participants in the simultaneous webcast register approximately 15 minutes prior to the scheduled presentation time of 11:30 a.m. to ensure a timely connection. Participants may also submit questions for the question-and-answer segment via e-mail to:
email@example.com. The webcast will be archived on the Company’s website for at least one month.
About TherapeuticsMD, Inc.
TherapeuticsMD, Inc. is a women’s healthcare company focused on developing and commercializing products targeted exclusively for women. TherapeuticsMD is developing advanced hormone therapy pharmaceutical products based on novel technologies that enable delivery of bioidentical hormones through a variety of dosage forms and administration routes. The company also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins and cosmetics, under our vitaMedMD
® and BocaGreenMD
® brands. More information is available at the following websites: